+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Global Pharmaceutical Contract Manufacturing And Research Services Market Size, Share & Trends Analysis Report by Service (Manufacturing, Research), by Region, and Segment Forecasts, 2021-2028

  • ID: 4312535
  • Report
  • July 2021
  • Region: Global
  • 180 pages
  • Grand View Research

FEATURED COMPANIES

  • AbbVie, Inc.
  • Aenova Holding GmbH
  • Boehringer Ingelheim GmbH
  • Catalent Pharma Solutions
  • Covance, Inc. (LabCorp)
  • Grifols S.A
  • MORE
The global pharmaceutical contract manufacturing and research services market size is expected to reach USD 276.8 billion by 2028. It is expected to expand at a CAGR of 5.75% from 2021 to 2028. The rising investments in R&D, increasing demand for generics, and the growing aging population with various chronic diseases are responsible for market growth.



The focus of large pharmaceutical companies to strategically engage with a small number of preferred providers is a meaningful solution from procurement-based outsourcing. This was one of the many business traits that this service industry has become accustomed to. Service providers that hold the potential of providing cost and quality advantages are set to make inroads and grow at a tremendous pace in the forecast period.

However, drug manufacturers are increasing their investments with respect to production capabilities. This may limit the potential growth of contract manufacturing services to traditional customers, thereby hampering industrial growth. However, the COVID-19 pandemic has provided new opportunities for pharmaceutical contract manufacturing and research services. Because of this pandemic, the contract service sector has switched its focus towards manufacturing COVID-19 therapies and vaccines. For example, 42 contract manufacturing services have publicly disclosed for 26 unique pipeline COVID-19 vaccines that they shall manufacture. The majority of vaccine manufacturers have been seen to partner with CMOs in locations, such as the U.K., the U.S., and Germany.

Pharmaceutical Contract Manufacturing And Research Services Market Report Highlights

  • By service, the manufacturing segment dominated the market in 2020. In this segment, Active Pharmaceutical Ingredient (API) / bulk drugs held the largest revenue share in 2020. Pharmaceutical companies prefer outsourcing services for API research and manufacturing owing to the reduction in the cost of production of APIs
  • In the manufacturing service segment, finished dose formulations are expected to register the fastest CAGR from 2021 to 2028
  • The research service segment is further segmented based on therapeutic area, wherein oncology held a significant share in 2020 and is anticipated to maintain its lead in the coming years
  • CMOs/CDMOs with the ability to establish facilities in emerging countries are expected to drive the market. The contract service sector is in its infancy in countries, including Brazil. Russia, India, and China
  • Companies can position themselves for strong growth, given that demand is expected to expand rapidly in the coming years. Increased competitiveness in the contract service sector is anticipated to ultimately benefit the sector growth

This report will be delivered within 1-3 business days

Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • AbbVie, Inc.
  • Aenova Holding GmbH
  • Boehringer Ingelheim GmbH
  • Catalent Pharma Solutions
  • Covance, Inc. (LabCorp)
  • Grifols S.A
  • MORE
Chapter 1 Research Methodology
1.1 Information Procurement
1.2 Data Analysis

Chapter 2 Executive Summary

Chapter 3 Market Variables, Trends & Scope
3.1 Market Segmentation & Scope
3.1.1 Market driver analysis
3.1.1.1 Drug shortage leading to drive demand for pharmaceutical development
3.1.1.2 Lower manufacturing costs and improving economic condition of BRIC
3.1.2 Market restraint analysis
3.1.2.1 Limited outsourcing among big pharma companies’ clients
3.1.2.2 Regulatory issues pertaining to the drug approval
3.2 Penetration &Growth Prospect Mapping, 2020
3.3 Pharmaceutical Contract Manufacturing & Research Services- SWOT Analysis, By Factor (political & legal, economic and technological)
3.4 Industry Analysis - Porter’s

Chapter 4 Pharmaceutical Contract Manufacturing & Research Services Market Categorization: Service Estimates & Trend Analysis
4.1 Pharmaceutical contract manufacturing & research services market: Service movement analysis
4.2 Manufacturing
4.2.1 Contract manufacturing services market, 2016 - 2028 (USD Billion)
4.2.2 API/bulk drugs
4.2.2.1 API/bulk drugs contract manufacturing market, 2016 - 2028 (USD Billion)
4.2.3 Advanced drug delivery formulations contract manufacturing
4.2.3.1 Advanced drug delivery formulations contract manufacturing services market, 2016 - 2028 (USD Billion)
4.2.4 Packaging
4.2.4.1 Packaging contract services market, 2016 - 2028 (USD Billion)
4.2.5 Finished dose formulations contract manufacturing
4.2.5.1 Finished dose formulations contract manufacturing market, 2016 - 2028 (USD Billion)
4.2.5.2 Solid finished dose formulations contract manufacturing
4.2.5.2.1 Solid finished dose formulations contract manufacturing market, 2016 - 2028 (USD Billion)
4.2.5.3 Liquid formulations
4.2.5.3.1 Liquid formulations contract manufacturing market, 2016 - 2028 (USD Billion)
4.2.5.4 Semi-solid formulations contract manufacturing
4.2.5.4.1 Semi-solid formulations contract manufacturing market, 2016 - 2028 (USD Billion)
4.3 Research
4.3.1 Research services market, 2016 - 2028 (USD Billion)
4.3.2 Oncology
4.3.2.1 Oncology market, 2016 - 2028 (USD Billion)
4.3.3 Vaccines
4.3.3.1 Vaccines market, 2016 - 2028 (USD Billion)
4.3.4 Inflammation & immunology
4.3.4.1 Inflammation & immunology market, 2016 - 2028 (USD Billion)
4.3.5 Cardiology
4.3.5.1 Cardiology market, 2016 - 2028 (USD Billion)
4.3.6 Neuroscience
4.3.6.1 Neuroscience market, 2016 - 2028 (USD Billion)
4.3.7 Others
4.3.7.1 Other research services market, 2016 - 2028 (USD Billion)

Chapter 5 Pharmaceutical Contract Manufacturing & Research Services Market Categorization: Regional Estimates & Trend Analysis, by Service
5.1 Market Share By Region, 2020 & 2028
5.2 North America
5.2.1 Market, 2016 - 2028 (USD Billion)
5.2.2 U.S.
5.2.2.1 Market, 2016 - 2028 (USD Billion)
5.2.3 Canada
5.2.3.1 Market, 2016 - 2028 (USD Billion)
5.3 Europe
5.3.1 Market, 2016 - 2028 (USD Billion)
5.3.2 Germany
5.3.2.1 Market, 2016 - 2028 (USD Billion)
5.3.3 France
5.3.3.1 Market, 2016 - 2028 (USD Billion)
5.4 Asia Pacific
5.4.1 Market, 2016 - 2028 (USD Billion)
5.4.2 India
5.4.2.1 Market, 2016 - 2028 (USD Billion)
5.4.3 China
5.4.3.1 Market, 2016 - 2028 (USD Billion)
5.5 Latin America
5.5.1 Market, 2016 - 2028 (USD Billion)
5.5.2 Brazil
5.5.2.1 Market, 2016 - 2028 (USD Billion)
5.5.3 Mexico
5.5.3.1 Market, 2016 - 2028 (USD Billion)
5.5.4 Colombia
5.5.4.1 Market, 2016 - 2028 (USD Billion)
5.5.5 Argentina
5.5.5.1 Market, 2016 - 2028 (USD Billion)
5.5.6 Chile
5.5.6.1 Market, 2016 - 2028 (USD Billion)
5.5.7 Venezuela
5.5.7.1 Market, 2016 - 2028 (USD Billion)
5.6 MEA
5.6.1 Market, 2016 - 2028 (USD Billion)
5.6.2 South Africa
5.6.2.1 Market, 2016 - 2028 (USD Billion)

Chapter 6 Competitive Landscape
6.1 Strategy Framework
6.2 Market Participation Categorization
6.3 Company Profiles
6.3.1 Boehringer Ingelheim GmbH
6.3.1.1 Company overview
6.3.1.2 Financial performance
6.3.1.3 Product benchmarking
6.3.1.4 Strategic initiatives
6.3.2 Lonza
6.3.2.1 Company overview
6.3.2.2 Financial performance
6.3.2.3 Product benchmarking
6.3.2.4 Strategic initiatives
6.3.3 Grifols S.A
6.3.3.1 Company overview
6.3.3.2 Financial performance
6.3.3.3 Product benchmarking
6.3.3.4 Strategic initiatives
6.3.4 Jubilant Life Sciences Limited
6.3.4.1 Company overview
6.3.4.2 Financial Performance
6.3.4.3 Product benchmarking
6.3.4.4 Strategic initiatives
6.3.5 Pfizer, Inc. (Pfizer CenterOne)
6.3.5.1 Company overview
6.3.5.2 Financial performance
6.3.5.3 Product benchmarking
6.3.5.4 Strategic initiatives
6.3.6 Charles River Laboratories International, Inc.
6.3.6.1 Company overview
6.3.6.2 Financial performance
6.3.6.3 Product benchmarking
6.3.6.4 Strategic initiatives
6.3.7 Albany Molecular Research, Inc.
6.3.7.1 Company overview
6.3.7.2 Financial performance
6.3.7.3 Product benchmarking
6.3.7.4 Strategic initiatives
6.3.8 Covance, Inc. (LabCorp)
6.3.8.1 Company overview
6.3.8.2 Financial performance
6.3.8.3 Product benchmarking
6.3.8.4 Strategic initiatives
6.3.9 QuintilesIMS
6.3.9.1 Company overview
6.3.9.2 Financial performance
6.3.9.3 Product benchmarking
6.3.9.4 Strategic initiatives
6.3.10 Baxter BioPharma Solutions
6.3.10.1 Company overview
6.3.10.2 Financial performance
6.3.10.3 Product benchmarking
6.3.10.4 Strategic initiatives
6.3.11 Aenova Holding GmbH
6.3.11.1 Company Overview
6.3.11.2 Financial performance
6.3.11.3 Product benchmarking
6.3.11.4 Strategic initiatives
6.3.12 Vetter Pharma
6.3.12.1 Company Overview
6.3.12.2 Financial performance
6.3.12.3 Product benchmarking
6.3.12.4 Strategic initiatives
6.3.13 Valeant Pharmaceuticals International Inc.
6.3.13.1 Company Overview
6.3.13.2 Financial performance
6.3.13.3 Product benchmarking
6.3.14 Ligand Pharmaceuticals, Inc.
6.3.14.1 Company Overview
6.3.14.2 Financial performance
6.3.14.3 Product benchmarking
6.3.14.4 Strategic initiatives
6.3.15 Pharmaceutical Product Development, LLC
6.3.15.1 Company Overview
6.3.15.2 Financial performance
6.3.15.3 Product benchmarking
6.3.15.4 Strategic initiatives
6.3.16 Recipharm AB.
6.3.16.1 Company Overview
6.3.16.2 Financial performance
6.3.16.3 Product benchmarking
6.3.16.4 Strategic initiatives
6.3.17 AbbVie, Inc.
6.3.17.1 Company Overview
6.3.17.2 Financial performance
6.3.17.3 Product benchmarking
6.3.17.4 Strategic initiatives
6.3.18 Famar Health Care Services
6.3.18.1 Company Overview
6.3.18.2 Financial performance
6.3.18.3 Product benchmarking
6.3.18.4 Strategic initiatives
6.3.19 Catalent Pharma Solutions
6.3.19.1 Company Overview
6.3.19.2 Financial performance
6.3.19.3 Product benchmarking
6.3.19.4 Strategic initiatives
6.3.20 West Pharmaceutical Services, Inc.
6.3.20.1 Company Overview
6.3.20.2 Financial performance
6.3.20.3 Product benchmarking
6.3.20.4 Strategic initiatives

List of Tables
Table 1 North America pharmaceutical contract manufacturing & research services market forecasts, by service, 2016 - 2028 (USD Billion)
Table 2 North America manufacturing & research services market forecasts, by service, 2016 - 2028 (USD Billion)
Table 3 North America finished dose formulations market forecasts, by service, 2016 - 2028 (USD Billion)
Table 4 North America research services market forecasts, by service, 2016 - 2028 (USD Billion)
Table 5 U.S. pharmaceutical contract manufacturing & research services market forecasts, by service, 2016 - 2028 (USD Billion)
Table 6 U.S. manufacturing & research services market forecasts, by service, 2016 - 2028 (USD Billion)
Table 7 U.S. finished dose formulations market forecasts, by service, 2016 - 2028 (USD Billion)
Table 8 U.S. research services market forecasts, by service, 2016 - 2028 (USD Billion)
Table 9 Canada pharmaceutical contract manufacturing & research services market forecasts, by service, 2016 - 2028 (USD Billion)
Table 10 Canada manufacturing & research services market forecasts, by service, 2016 - 2028 (USD Billion)
Table 11 Canada finished dose formulations market forecasts, by service, 2016 - 2028 (USD Billion)
Table 12 Canada research services market forecasts, by service, 2016 - 2028 (USD Billion)
Table 13 Europe pharmaceutical contract manufacturing & research services market forecasts, by service, 2016 - 2028 (USD Billion)
Table 14 Europe manufacturing & research services market forecasts, by service, 2016 - 2028 (USD Billion)
Table 15 Europe finished dose formulations market forecasts, by service, 2016 - 2028 (USD Billion)
Table 16 Europe research services market forecasts, by service, 2016 - 2028 (USD Billion)
Table 17 Germany pharmaceutical contract manufacturing & research services market forecasts, by service, 2016 - 2028 (USD Billion)
Table 18 Germany manufacturing & research services market forecasts, by service, 2016 - 2028 (USD Billion)
Table 19 Germany finished dose formulations market forecasts, by service, 2016 - 2028 (USD Billion)
Table 20 Germany research services market forecasts, by service, 2016 - 2028 (USD Billion)
Table 21 France pharmaceutical contract manufacturing & research services market forecasts, by service, 2016 - 2028 (USD Billion)
Table 22 France manufacturing & research services market forecasts, by service, 2016 - 2028 (USD Billion)
Table 23 France finished dose formulations market forecasts, by service, 2016 - 2028 (USD Billion)
Table 24 France research services market forecasts, by service, 2016 - 2028 (USD Billion)
Table 25 Asia Pacific pharmaceutical contract manufacturing & research services market forecasts, by service, 2016 - 2028 (USD Billion)
Table 26 Asia Pacific manufacturing & research services market forecasts, by service, 2016 - 2028 (USD Billion)
Table 27 Asia Pacific finished dose formulations market forecasts, by service, 2016 - 2028 (USD Billion)
Table 28 Asia Pacific research services market forecasts, by service, 2016 - 2028 (USD Billion)
Table 29 India pharmaceutical contract manufacturing & research services market forecasts, by service, 2016 - 2028 (USD Billion)
Table 30 India manufacturing & research services market forecasts, by service, 2016 - 2028 (USD Billion)
Table 31 India finished dose formulations market forecasts, by service, 2016 - 2028 (USD Billion)
Table 32 India research services market forecasts, by service, 2016 - 2028 (USD Billion)
Table 33 China pharmaceutical contract manufacturing & research services market forecasts, by service, 2016 - 2028 (USD Billion)
Table 34 China manufacturing & research services market forecasts, by service, 2016 - 2028 (USD Billion)
Table 35 China finished dose formulations market forecasts, by service, 2016 - 2028 (USD Billion)
Table 36 China research services market forecasts, by service, 2016 - 2028 (USD Billion)
Table 37 Latin America pharmaceutical contract manufacturing & research services market forecasts, by service, 2016 - 2028 (USD Billion)
Table 38 Latin America manufacturing & research services market forecasts, by service, 2016 - 2028 (USD Billion)
Table 39 Latin America finished dose formulations market forecasts, by service, 2016 - 2028 (USD Billion)
Table 40 Latin America research services market forecasts, by service, 2016 - 2028 (USD Billion)
Table 41 Brazil pharmaceutical contract manufacturing & research services market forecasts, by service, 2016 - 2028 (USD Billion)
Table 42 Brazil manufacturing & research services market forecasts, by service, 2016 - 2028 (USD Billion)
Table 43 Brazil finished dose formulations market forecasts, by service, 2016 - 2028 (USD Billion)
Table 44 Brazil research services market forecasts, by service, 2016 - 2028 (USD Billion)
Table 45 Mexico pharmaceutical contract manufacturing & research services market forecasts, by service, 2016 - 2028 (USD Billion)
Table 46 Mexico manufacturing & research services market forecasts, by service, 2016 - 2028 (USD Billion)
Table 47 Mexico finished dose formulations market forecasts, by service, 2016 - 2028 (USD Billion)
Table 48 Mexico research services market forecasts, by service, 2016 - 2028 (USD Billion)
Table 49 Colombia pharmaceutical contract manufacturing & research services market forecasts, by service, 2016 - 2028 (USD Billion)
Table 50 Colombia manufacturing & research services market forecasts, by service, 2016 - 2028 (USD Billion)
Table 51 Colombia finished dose formulations market forecasts, by service, 2016 - 2028 (USD Billion)
Table 52 Colombia research services market forecasts, by service, 2016 - 2028 (USD Billion)
Table 53 Argentina pharmaceutical contract manufacturing & research services market forecasts, by service, 2016 - 2028 (USD Billion)
Table 54 Argentina manufacturing & research services market forecasts, by service, 2016 - 2028 (USD Billion)
Table 55 Argentina finished dose formulations market forecasts, by service, 2016 - 2028 (USD Billion)
Table 56 Argentina research services market forecasts, by service, 2016 - 2028 (USD Billion)
Table 57 Chile pharmaceutical contract manufacturing & research services market forecasts, by service, 2016 - 2028 (USD Billion)
Table 58 Chile manufacturing & research services market forecasts, by service, 2016 - 2028 (USD Billion)
Table 59 Chile finished dose formulations market forecasts, by service, 2016 - 2028 (USD Billion)
Table 60 Chile research services market forecasts, by service, 2016 - 2028 (USD Billion)
Table 61 Venezuela pharmaceutical contract manufacturing & research services market forecasts, by service, 2016 - 2028 (USD Billion)
Table 62 Venezuela manufacturing & research services market forecasts, by service, 2016 - 2028 (USD Billion)
Table 63 Venezuela finished dose formulations market forecasts, by service, 2016 - 2028 (USD Billion)
Table 64 Venezuela research services market forecasts, by service, 2016 - 2028 (USD Billion)
Table 65 MEA pharmaceutical contract manufacturing & research services market forecasts, by service, 2016 - 2028 (USD Billion)
Table 66 MEA manufacturing & research services market forecasts, by service, 2016 - 2028 (USD Billion)
Table 67 MEA finished dose formulations market forecasts, by service, 2016 - 2028 (USD Billion)
Table 68 MEA research services market forecasts, by service, 2016 - 2028 (USD Billion)
Table 69 South Africa pharmaceutical contract manufacturing & research services market forecasts, by service, 2016 - 2028 (USD Billion)
Table 70 South Africa manufacturing & research services market forecasts, by service, 2016 - 2028 (USD Billion)
Table 71 South Africa finished dose formulations market forecasts, by service, 2016 - 2028 (USD Billion)
Table 72 South Africa research services market forecasts, by service, 2016 - 2028 (USD Billion)

List of Figures
Fig. 1 Market research process
FIG. 2 Information procurement
FIG. 3 Primary research pattern
FIG. 4 Market research approaches
FIG. 5 Value chain based sizing & forecasting
FIG. 6 QFD modelling for market share assessment
FIG. 7 Market summary
FIG. 8 Market trends & outlook
FIG. 9 Market segmentation & scope
FIG. 10 Market driver relevance analysis (current & future impact)
FIG. 11 Factors playing role in drug shortfall
FIG. 12 Market restraint relevance analysis (current & future impact)
FIG. 13 Penetration & growth prospect mapping, 2016
FIG. 14 SWOT Analysis, By Factor (political & legal, economic and technological)
FIG. 15 Porter’s Five Forces Analysis
FIG. 16 Pharmaceutical contract manufacturing & research services: Service outlook key takeaways
FIG. 17 Top five activities by average percentage of activity outsourced
FIG. 18 Pharmaceutical contract manufacturing & research services: Service movement analysis
FIG. 19 Survey study for outsourcing needs
FIG. 20 Contract manufacturing & research services market, 2016 - 2028 (USD Billion)
FIG. 21 API/bulk drugs contract manufacturing market, 2016 - 2028 (USD Billion)
FIG. 22 Advanced drug delivery formulations market, 2016 - 2028 (USD Billion)
FIG. 23 Packaging contract services market, 2016 - 2028 (USD Billion)
FIG. 24 Finished dose formulations market, 2016 - 2028 (USD Billion)
FIG. 25 Solid finished dose formulations contract manufacturing market, 2016 - 2028 (USD Billion)
FIG. 26 Liquid formulations contract manufacturing market, 2016 - 2028 (USD Billion)
FIG. 27 Semi-solid formulations contract manufacturing market, 2016 - 2028 (USD Billion)
FIG. 28 Contract research services market, 2016 - 2028 (USD Billion)
FIG. 29 Oncology market, 2016 - 2028 (USD Billion)
FIG. 30 Breakdown of vaccines on the basis of availability
FIG. 31 Vaccines market, 2016 - 2028 (USD Billion)
FIG. 32 Inflammation & immunology market, 2016 - 2028 (USD Billion)
FIG. 33 Cardiology market, 2016 - 2028 (USD Billion)
FIG. 34 Neuroscience market, 2016 - 2028 (USD Billion)
FIG. 35 Other research services market, 2016 - 2028 (USD Billion)
FIG. 36 Regional market place: Key takeaway
FIG. 37 Global pharmaceutical contract manufacturing & research services country outlook, 2020 & 2028
FIG. 38 North America pharmaceutical contract manufacturing & research services market, 2016 - 2028 (USD Billion)
FIG. 39 U.S. pharmaceutical contract manufacturing & research services market, 2016 - 2028 (USD Billion)
FIG. 40 Canada pharmaceutical contract manufacturing & research services market, 2016 - 2028 (USD Billion)
FIG. 41 Europe pharmaceutical contract manufacturing & research services market, 2016 - 2028 (USD Billion)
FIG. 42 Germany pharmaceutical contract manufacturing & research services market, 2016 - 2028 (USD Billion)
FIG. 43 France pharmaceutical contract manufacturing & research services market, 2016 - 2028 (USD Billion)
FIG. 44 Asia Pacific pharmaceutical contract manufacturing & research services market, 2016 - 2028 (USD Billion)
FIG. 45 India pharmaceutical contract manufacturing & research services market, 2016 - 2028 (USD Billion)
FIG. 46 China pharmaceutical contract manufacturing & research services market, 2016 - 2028 (USD Billion)
FIG. 47 Latin America pharmaceutical contract manufacturing & research services market, 2016 - 2028 (USD Billion)
FIG. 48 Brazil pharmaceutical contract manufacturing & research services market, 2016 - 2028 (USD Billion)
FIG. 49 Mexico pharmaceutical contract manufacturing & research services market, 2016 - 2028 (USD Billion)
FIG. 50 Colombia pharmaceutical contract manufacturing & research services market, 2016 - 2028 (USD Billion)
FIG. 51 Argentina pharmaceutical contract manufacturing & research services market, 2016 - 2028 (USD Billion)
FIG. 52 Chile pharmaceutical contract manufacturing & research services market, 2016 - 2028 (USD Billion)
FIG. 53 Venezuela pharmaceutical contract manufacturing & research services market, 2016 - 2028 (USD Billion)
FIG. 54 MEA pharmaceutical contract manufacturing & research services market, 2016 - 2028 (USD Billion)
FIG. 55 South Africa pharmaceutical contract manufacturing & research services market, 2016 - 2028 (USD Billion)
FIG. 56 Strategy framework
FIG. 57 Participant categorization
Note: Product cover images may vary from those shown
  • Boehringer Ingelheim GmbH
  • Lonza
  • Grifols S.A
  • Jubilant Life Sciences Limited
  • Pfizer, Inc. (Pfizer CenterOne)
  • Charles River Laboratories International, Inc.
  • Albany Molecular Research, Inc.
  • Covance, Inc. (LabCorp)
  • QuintilesIMS
  • Baxter BioPharma Solutions
  • Aenova Holding GmbH
  • Vetter Pharma
  • Valeant Pharmaceuticals International Inc.
  • Ligand Pharmaceuticals, Inc.
  • Pharmaceutical Product Development, LLC
  • Recipharm AB.
  • AbbVie, Inc.
  • Famar Health Care Services
  • Catalent Pharma Solutions
  • West Pharmaceutical Services, Inc.
Note: Product cover images may vary from those shown

Loading
LOADING...

Adroll
adroll